DaVita Inc. (DVA)
DaVita Stock Benefits From Expanding Community-Based Kidney Care
DVA is expanding kidney care through outpatient, home-centered and value-based programs while investing in AI-enabled scheduling.
Best Growth Stocks to Buy for June 24th
HRB, DVA and PBI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 24th, 2026.
DVA vs. FMS: Which Dialysis Leader Is Better Positioned Now?
DaVita and Fresenius Medical Care are taking different paths in kidney care, but which stock offers stronger upside now? Let's dive in.
Best Growth Stocks to Buy for June 22nd
HRB, DVA and PBI made it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 22nd, 2026.
DaVita HealthCare (DVA) Stock Dips While Market Gains: Key Facts
DaVita HealthCare (DVA) closed the most recent trading day at $207.91, moving 1.27% from the previous trading session.
4 Stocks Trading Near 52-Week High With Room to Rise Further
Investors target stocks that have been on a bullish run. Stocks like MUSA, DVA, HPE and VSH are seeing price strength, and the momentum is likely to continue.
DaVita Expands Specialized Care Beyond Acute Settings Through IKC
DVA is expanding kidney care beyond hospitals with IKC, digital tools and AI to improve coordination, lower costs and support patients.
Best Growth Stocks to Buy for June 17th
DVA, FIVE, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 17, 2026.
Best Growth Stocks to Buy for June 15th
DVA, FIVE, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 15, 2026.
DaVita HealthCare (DVA) Exceeds Market Returns: Some Facts to Consider
In the most recent trading session, DaVita HealthCare (DVA) closed at $203.83, indicating a +2.66% shift from the previous trading day.
DaVita HealthCare (DVA) Moves to Strong Buy: Rationale Behind the Upgrade
DaVita HealthCare (DVA) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Best Growth Stocks to Buy for June 11th
DVA, HRB, and PBI it to the Zacks Rank #1 (Strong Buy) growth stocks list on June 11, 2026.
